Decreased expression of DAB2IP in ESCCs correlated positively with ESCC resistance to CRT and was a strong and independent predictor for short disease-specific survival (DSS) of ESCC patients. The gene discussed is DAB2IP; the disease is esophageal squamous cell carcinoma.